ATNF
Price
$1.00
Change
+$0.05 (+5.26%)
Updated
Apr 2 closing price
Capitalization
3.18M
PRQR
Price
$1.37
Change
+$0.08 (+6.20%)
Updated
Apr 2 closing price
Capitalization
144.14M
35 days until earnings call
Ad is loading...

ATNF vs PRQR

Header iconATNF vs PRQR Comparison
Open Charts ATNF vs PRQRBanner chart's image
180 Life Sciences
Price$1.00
Change+$0.05 (+5.26%)
Volume$12.38K
Capitalization3.18M
ProQR Therapeutics
Price$1.37
Change+$0.08 (+6.20%)
Volume$442.94K
Capitalization144.14M
ATNF vs PRQR Comparison Chart
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. PRQR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a StrongBuy and PRQR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ATNF: $1.00 vs. PRQR: $1.37)
Brand notoriety: ATNF and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 18% vs. PRQR: 86%
Market capitalization -- ATNF: $3.18M vs. PRQR: $144.14M
ATNF [@Biotechnology] is valued at $3.18M. PRQR’s [@Biotechnology] market capitalization is $144.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, PRQR is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 3 bullish TA indicator(s).

  • ATNF’s TA Score: 4 bullish, 4 bearish.
  • PRQR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ATNF is a better buy in the short-term than PRQR.

Price Growth

ATNF (@Biotechnology) experienced а -5.66% price change this week, while PRQR (@Biotechnology) price change was -9.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

ATNF is expected to report earnings on Mar 01, 2023.

PRQR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($144M) has a higher market cap than ATNF($3.18M). ATNF YTD gains are higher at: -45.055 vs. PRQR (-48.302). ATNF has higher annual earnings (EBITDA): -2.99M vs. PRQR (-24.12M). PRQR has more cash in the bank: 149M vs. ATNF (195K). ATNF has less debt than PRQR: ATNF (3.26M) vs PRQR (17.2M). PRQR has higher revenues than ATNF: PRQR (18.9M) vs ATNF (0).
ATNFPRQRATNF / PRQR
Capitalization3.18M144M2%
EBITDA-2.99M-24.12M12%
Gain YTD-45.055-48.30293%
P/E Ratio0.13N/A-
Revenue018.9M-
Total Cash195K149M0%
Total Debt3.26M17.2M19%
FUNDAMENTALS RATINGS
ATNF vs PRQR: Fundamental Ratings
ATNF
PRQR
OUTLOOK RATING
1..100
474
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
9194
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (30) in the Biotechnology industry is in the same range as ATNF (57) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ATNF’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ATNF’s over the last 12 months.

PRQR's SMR Rating (97) in the Biotechnology industry is in the same range as ATNF (99) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ATNF’s over the last 12 months.

ATNF's Price Growth Rating (91) in the Financial Conglomerates industry is in the same range as PRQR (94) in the Biotechnology industry. This means that ATNF’s stock grew similarly to PRQR’s over the last 12 months.

ATNF's P/E Growth Rating (96) in the Financial Conglomerates industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ATNF’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNFPRQR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE10.620.71
+7.16%
uniQure NV
COYA6.540.23
+3.65%
Coya Therapeutics
ITT133.442.29
+1.75%
ITT
CNMD60.431.03
+1.73%
CONMED Corp
SCNI2.850.04
+1.42%
Scinai Immunotherapeutics Ltd.

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
+5.26%
PRQR - ATNF
56%
Loosely correlated
+6.20%
KRRO - ATNF
43%
Loosely correlated
+8.71%
WVE - ATNF
41%
Loosely correlated
-2.20%
JSPR - ATNF
41%
Loosely correlated
+2.17%
XAGE - ATNF
38%
Loosely correlated
+4.60%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+6.20%
KRRO - PRQR
59%
Loosely correlated
+8.71%
ATNF - PRQR
56%
Loosely correlated
+5.26%
WVE - PRQR
55%
Loosely correlated
-2.20%
ENVB - PRQR
43%
Loosely correlated
+3.82%
LOGC - PRQR
32%
Poorly correlated
+3.40%
More